ERA

Download the full-sized PDF of Maternal Essential Fatty Acid Status During Pregnancy and Postpartum in the Alberta Pregnancy Outcomes and Nutrition (APrON) Study and Infant OutcomesDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R37H1F01F

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Maternal Essential Fatty Acid Status During Pregnancy and Postpartum in the Alberta Pregnancy Outcomes and Nutrition (APrON) Study and Infant Outcomes Open Access

Descriptions

Other title
Subject/Keyword
nutrition
infant crying
arachidonic acid
docosahexaenoic acid
APrON
lactation
breast milk
dietary intake
pregnancy
infant sleep
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Wattar, Nour
Supervisor and department
Field, Catherine (Agricultural, Food and Nutritional Science)
Examining committee member and department
Carla Prado (Agricultural, Food and Nutritional Science)
Gerald Giesbrecht (Paediatrics and Community Health Sciences)
Bell, Rhonda (Agricultural, Food and Nutritional Science)
Department
Department of Agricultural, Food, and Nutritional Science
Specialization
Nutrition and Metabolism
Date accepted
2017-02-01T14:34:58Z
Graduation date
2017-06:Spring 2017
Degree
Master of Science
Degree level
Master's
Abstract
Docosahexaenoic (DHA) and arachidonic (AA) acids are essential fatty acids found in breast milk and are important for the infant’s brain development and cognitive functions such as those that regulate sleep and crying. The overall goal of this research was to use a large maternal infant cohort, Alberta Pregnancy Outcomes and Nutrition (APrON), to establish the relationship between maternal intake and status of DHA and AA across pregnancy and at three months postpartum, their levels in breast milk and infant sleep and crying outcomes. The cohort participants were mainly older women with a healthy BMI and high socioeconomic status. Dietary intake of DHA and AA was estimated using 24-hr recalls collected at each trimester and at three months postpartum. Food Processor (version 10.6; ESHA Research, Salem, Ore., USA) output was used to estimate AA (n=129, n=564, n=497, n=485 at the four time points, respectively) and a previously established nutrient n-3 database for DHA. DHA from supplement intake was estimated using Supplement Intake Questionnaire (SIQ) and the total DHA intake form diet and supplement was included in the analysis at each time point (n=239, n=998, n=882, n=827, respectively). Maternal blood samples were collected at the same four time points, and the relative percent and concentration of fatty acids in serum PL were assessed by gas liquid chromatography (GLC) (n=280, n=1059, n=713, n=907, respectively). Breast milk samples (n=1038) were obtained at the third month of lactation, and the relative fatty acid composition of DHA and AA was determined using GLC. Brief Infant Sleep Questionnaire (n=785) and Crying Patterns Questionnaire data (n=839) were used to assess the reported durations of infant sleep and crying, and whether parents considered them to be problematic. Statistical analyses were completed using SPSS Version 23.0 (IBM Corporation, Armonk, NY, USA). While AA intake did not change during pregnancy or lactation, DHA intake increased from the second to the third trimester (p=0.01), and the median DHA intake estimate for the cohort did not meet the European Consensus recommendation of 200 mg/day at any time point in the study. The serum concentrations of both DHA and AA increased during pregnancy and decreased postpartum and the relative proportion of DHA followed the same pattern (p<0.001 for all). Postpartum, DHA concentration in serum PL was 35±20 µg/mL (2.0±0.9%) and AA at 136±56 µg/mL (7.9±2.1%). The DHA proportion of fatty acids in breast milk (median: 0.2%, IQR: 0.1-0.3%) was found to be lower than the reported global average, while AA (median: 0.8%, IQR: 0.5-1.4%) was found to be higher. Breast milk content of DHA was significantly correlated to postpartum DHA concentration in the serum and estimated DHA intake (p<0.001 for all). The proportion of AA in breast milk was found to directly relate to serum concentration (p<0.001) but not dietary intake. Using the data in this study, to achieve a breast milk concentration (0.30-0.64%), women need to consume DHA of 340-1600 mg/day or maintain a maternal PL DHA status of at least 45 µg/mL or 2.7% (w/w) of total serum PL fatty acids. No relationships were found between DHA or AA in breast milk and parental reported infant sleep or crying behaviour. In summary, approximately 75% of women in the APrON cohort were not meeting current dietary recommendations for DHA. The mean concentration of DHA in breast milk at three months postpartum was below the level considered optimal. Using this cohort, we have identified dietary intake recommendations and a maternal status reference that could be useful as a target for dietary interventions to optimize the concentration of DHA in breast milk.
Language
English
DOI
doi:10.7939/R37H1F01F
Rights
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication

File Details

Date Uploaded
Date Modified
2017-02-01T21:34:59.554+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (PDF/A)
Mime type: application/pdf
File size: 4244776
Last modified: 2017:06:13 12:27:01-06:00
Filename: Wattar_Nour_201701_MSc.pdf
Original checksum: ab6222f699e9978349ee45b20aaa1b37
Activity of users you follow
User Activity Date